403 results found
We are experts in the protection of intellectual property and we work with our clients to create strategies with high commercial impact. Founded over…
FB Rice | New Zealand | 26 Nov 2023
Enhancements to the New to R&D Grant: A boon for start-ups in New Zealand
Discover how New Zealand's revamped New to R&D Grant fosters innovation in start-ups. With increased co-funding of 40% and a focus on long-term R&D…
FB Rice | Australia | 8 Nov 2023
Could you be getting your R&D tax claim wrong? What the ATO is focusing on
Although the Research and Development Tax Incentive (RDTI) program is a self-assessed program, RDTI applications can be subject to a review at any…
FB Rice | Australia | 23 Oct 2023
From Kevlar to Post-it notes: bullet proof IP tips for polymers
Polymers are abundant in daily life. The ability to tailor their properties for a raft of practices make them attractive materials for diverse…
FB Rice | Australia, New Zealand | 5 Oct 2023
New Zealand launches National Space Policy
World Space Week, an international celebration of science and technology, is observed 4-10 October. The annual event presents an opportunity to focus…
FB Rice | Australia, USA | 5 Oct 2023
CAR-T cell therapy: Understanding the patent landscape
The CAR-T cell patent landscape has seen exponential growth in the past decade. This article, the third in a series, highlights the significance of…
FB Rice | Australia, USA | 26 Sep 2023
CAR-T cell therapy: Manage your patent term to create an investible patent strategy
Effective patent strategy manages the tension between the challenging commercial realities of long development times and the finite nature of patent…
FB Rice | Australia, USA | 19 Sep 2023
CAR-T cell therapy: Creating an investible patent strategy in a crowded market
CAR-T cell therapy, a transformative force in cancer treatment, has rapidly gained momentum since obtaining first US marketing approval in 2017. The…
FB Rice | Australia | 24 Aug 2023
Lipid Nanoparticles for RNA vaccines - Even more layers of patents
In our previous article, we discussed the patent litigation landscape relating to the mRNA components of mRNA vaccines. In this article, we look at…
FB Rice | Australia | 17 Aug 2023
Peeling back the layers and exploring the landscape of mRNA patent freedom-to-operate
Conducting a freedom-to-operate analysis often involves peeling back several layers of patents that potentially encompass a product you wish to…
